LabGenomics Relocates and Expands to Korea Bio Park in Pangyo... "A Second Leap Forward"

Interior view of LabGenomics' new office building.

Genome molecular diagnostics specialist LabGenomics announced on the 2nd that it has consolidated its dispersed offices and relocated to Pangyo Korea Bio Park.

The company stated, "This expansion is based on global business growth and IT diversification to recruit talent and foster growth," adding, "We will prepare to enhance management efficiency and achieve a greater leap forward."

Previously, LabGenomics had sales offices, diagnostic testing centers, R&D (research and development) laboratories, business departments, and administrative departments located nationwide. Through this consolidation, faster work processing and integrated strategy formulation have become possible.

Along with this, the company simplified its rank system to improve work efficiency and organizational culture. It also reorganized the workspace to create a comfortable working environment by establishing large conference rooms, an in-house cafe, and a lounge area.

A LabGenomics representative said, "By integrating the workspaces of research, sales, and administrative staff into one, mutual understanding of tasks has increased," and added, "Improved communication between departments and faster decision-making are expected to create work synergies."

They continued, "By bringing together previously scattered capabilities, 2024 will be the year that creates LabGenomics' 'second leap'."

Meanwhile, in August, LabGenomics acquired the mid-to-large-sized US company CleaLab QDX, headquartered in New Jersey. The company is accelerating its global business expansion and digital healthcare initiatives.

This content was produced with the assistance of AI translation services.